Phytotherapy Research

Papers
(The H4-Index of Phytotherapy Research is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Quercetin and its derivates as antiviral potentials: A comprehensive review207
Quercetin and metabolic syndrome: A review190
Natural products: A lead for drug discovery and development147
Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects112
Molecular mechanisms of anticancer effect of rutin111
The review of alpha‐linolenic acid: Sources, metabolism, and pharmacology97
Anti‐inflammatory effect of Rhein on ulcerative colitis via inhibiting PI3K/Akt/mTOR signaling pathway and regulating gut microbiota94
Oral nano‐curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease‐19 patients: An open label nonrandomized clinical trial90
Biological and pharmacological effects and nutritional impact of phytosterols: A comprehensive review83
Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in cultured Vero cells82
Ganoderma lucidum (Reishi) an edible mushroom; a comprehensive and critical review of its nutritional, cosmeceutical, mycochemical, pharmacological, clinical, and toxicological properties77
In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS‐CoV‐2 main protease (3CLpro)77
Botanical drugs and supplements affecting the immune response in the time of COVID‐19: Implications for research and clinical practice77
Anticancer activity of the plant flavonoid luteolin against preclinical models of various cancers and insights on different signalling mechanisms modulated72
Wogonin and its analogs for the prevention and treatment of cancer: A systematic review72
Efficacy and safety of Xiyanping injection in the treatment of COVID‐19: A multicenter, prospective, open‐label and randomized controlled trial71
A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents70
Curcumin nanoformulations: Beneficial nanomedicine against cancer69
Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery, recent patents, and clinical trials67
Citrus flavonoids as potential therapeutic agents: A review67
A comprehensive review of the therapeutic potential of α‐arbutin66
Andrographolide: A review of its pharmacology, pharmacokinetics, toxicity and clinical trials and pharmaceutical researches65
Chemistry, pharmacokinetics, pharmacological activities, and toxicity of Quercitrin62
Quercetin as a protective agent for liver diseases: A comprehensive descriptive review of the molecular mechanism62
Spices and herbs: Potential antiviral preventives and immunity boosters duringCOVID‐1961
Promising influences ofScutellaria baicalensisand its two active constituents, baicalin, and baicalein, against metabolic syndrome: A review60
Curcumin supplementation in pediatric patients: A systematic review of current clinical evidence59
Bacosides from Bacopa monnieri extract: An overview of the effects on neurological disorders57
Kaempferol exerts a neuroprotective effect to reduce neuropathic pain throughTLR4/NF‐ĸBsignaling pathway57
A triple‐blind, placebo‐controlled, randomized clinical trial to evaluate the effect of curcumin‐containing nanomicelles on cellular immune responses subtypes and clinical outcome inCOVID‐156
Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview55
Effects of phytochemicals on macrophage cholesterol efflux capacity: Impact on atherosclerosis54
Berberine as a natural modulator of inflammatory signaling pathways in the immune system: Focus on NF‐κB, JAK/STAT, and MAPK signaling pathways54
Natural products: The role and mechanism in low‐density lipoprotein oxidation and atherosclerosis53
Emodin alleviates LPS‐induced myocardial injury through inhibition of NLRP3 inflammasome activation52
Effects of quercetin supplementation on inflammatory factors and quality of life in post‐myocardial infarction patients: A double blind, placebo‐controlled, randomized clinical trial52
Curcumin‐piperine co‐supplementation and human health: A comprehensive review of preclinical and clinical studies52
Medicinal plants: Treasure for antiviral drug discovery52
Hyperoside: A review on its sources, biological activities, and molecular mechanisms52
New insights into the role of the Nrf2 signaling pathway in green tea catechin applications51
Curcumin–cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects51
Is it safe to consume traditional medicinal plants during pregnancy?51
Immunomodulatory effects of polysaccharides from marine algae for treating cancer, infectious disease, and inflammation50
Bergapten: A review of its pharmacology, pharmacokinetics, and toxicity49
Quercetin promotes osteogenic differentiation and antioxidant responses of mouse bone mesenchymal stem cells through activation of the AMPK/SIRT1 signaling pathway49
A pharmacology‐based comprehensive review on medicinal plants and phytoactive constituents possibly effective in the management of COVID‐1947
Apoptosis and autophagy modulating dietary phytochemicals in cancer therapeutics: Current evidences and future perspectives47
0.11457300186157